Global Estrogen Replacement Therapy market likely to promulgate by the increase in demand for estrogen replacement therapy for treating women suffering from menopausal symptoms
Global Estrogen Replacement Therapy market estimated to grow with a significant rate during the forecast period, 2020-2027. It is owing to hormonal imbalance disorders in women, including menopause. These hormone levels get altered in women with growing age, leading to various disorders and diseases. Estrogen replacement therapy helps in preventing women's osteoporosis, a consequence of lowered estrogen levels. Estrogen therapy used to reduce the short-term changes of menopause, such as hot flashes, disturbed sleep, and vaginal dryness. Moreover, the increasing demand for Estrogen replacement theory to relieve the symptoms of the menopausal syndrome such as facial hot flashes and night sweats and growing uses of ERT for vaginal and vulvar atrophy in menopausal women will propel the global estrogen replacement therapy market in the projected periods.
ERT can improve the pain associated with sexual intercourse, one of the most common causes of sexual apathy in menopausal women. Estrogen therapy can apply to the skin, such as patches, gels, and sprays. These low dose estrogen pills, which are approved by the United States Food and Drug Administration (FDA) have been helpful for lower risks of blood clots and strokes than standard doses of estrogen pills. It reduces the risk of colon cancer. In addition, a growing need for Estrogen to protect against the bone-thinning disease and to treat vaginal symptoms and urinary symptoms into the body will fuel the global Estrogen replacement therapy market.
Dosages form Overview in the Global Estrogen Replacement Therapy Market
Based on dosages form, the global Estrogen Replacement Therapy market classified into Patches, Tablets, Gels/Creams, Suppositories, Implants, and Injections. The Tablets segment will lead the market on account of its help in relieving menopause symptoms, maintain vaginal health, helps ovary issues, and protect bones.
Routes of administration Overview in the Global Estrogen Replacement Therapy Market
Based on routes of administration, the global Estrogen Replacement Therapy market categorized into Oral, Topical, Subcutaneous Pellets, Injection, and Others. The oral segment likely to lead the market by 2027, based on easy availability as a vaginal ring, topical spray, cream, or gel. It is the most common form of ERT and reduces or resolves troublesome symptoms of menopause.
End-User Industry Overview in the Global Estrogen Replacement Therapy Market
Based on end-user, the global Estrogen replacement therapy market classified into Hospitals, Clinics, Pharmacy stores, and others. Hospitals segment expected to generate maximum revenue by 2027 due to the increase in the number of hospitals in developing countries along with rising awareness among women regarding the menopausal symptoms worldwide.
Regional Overview in the Global Estrogen Replacement Therapy Market
By geography, the Global Estrogen Replacement Therapy Market segmented into North America, Europe, Asia Pacific, Middle East & Africa, and South America. North America dominates the market based on rising disposables income level, improving health care awareness levels along with the surge in demand for Estrogen Replacement Therapy old aged women in these regions.
Global Estrogen Replacement Therapy Market: Competitive Landscape
Companies such as AbbVie, Inc., Bayer AG, Hisamitsu Pharmaceutical Co., Inc., Novartis AG, Novo Nordisk A/S, Orion Pharma AB, Pfizer, Inc., Meda Pharmaceuticals, Teva Pharmaceutical Industries Ltd. and TherapeuticsMD, Inc. are the key players in the Global Estrogen Replacement Therapy Market.
Global Estrogen Replacement Therapy Market Report Content 1. Research Strategic Development 1.1. Market Modelling 1.2. Product Analysis 1.3. Market Trend and Economic Factors Analysis 1.4. Market Segmental Analysis 1.5. Geographical Mapping 1.6. Country Wise Segregation 2. Research Methodology 2.1. Identification of Target Market 2.2. Data Acquisition 2.3. Refining of Data/ Data Transformations 2.4. Data Validation through Primary Techniques 2.5. Exploratory Data Analysis 2.6. Graphical Techniques/Analysis 2.7. Quantitative Techniques/Analysis 2.8. Visual Result/Presentation 3. Executive Summary 4. Market Insights 4.1. Economic Factor Analysis 4.1.1. Drivers 4.1.2. Trends 4.1.3. Opportunities 4.1.4. Challenges 4.2. Technological Landscape 4.3. Competitors & Product Analysis 4.4. Regulatory Framework 4.5. Company market share analysis, 2019 4.6. Porter's Five forces analysis 4.7. New Investment Analysis 4.8. PESTEL Analysis 5. Global Estrogen Replacement Therapy Market Overview 5.1. Market Size & Forecast, 2016-2027 5.1.1. Demand 5.1.1.1. By Value (USD Million) 5.2. Market Share & Forecast, 2016-2027 5.2.1. By Dosage Forms 5.2.1.1. Patches 5.2.1.2. Tablets 5.2.1.3. Gels/Creams 5.2.1.4. Suppositories Implants 5.2.1.5. Injections 5.2.2. By Routes of Administration 5.2.2.1. Oral 5.2.2.2. Topical 5.2.2.3. Subcutaneous Pellets 5.2.2.4. Injections 5.2.2.5. Others 5.2.3. By End-User 5.2.3.1. Hospitals 5.2.3.2. Clinics 5.2.3.3. Pharmacy Store 5.2.3.4. Others 5.2.4. By Region 5.2.4.1. North America 5.2.4.2. Europe 5.2.4.3. Asia Pacific 5.2.4.4. South America 5.2.4.5. Middle East & Africa 6. North America Estrogen Replacement Therapy Market Overview 6.1. North America Estrogen Replacement Therapy Market Size & Forecast, 2016-2027 6.1.1. Demand 6.1.1.1. By Value (USD Million) 6.2. North America Estrogen Replacement Therapy Market Share & Forecast, 2016-2027 6.2.1. By Dosage Forms 6.2.1.1. Patches 6.2.1.2. Tablets 6.2.1.3. Gels/Creams 6.2.1.4. Suppositories Implants 6.2.1.5. Injections 6.2.2. By Routes of Administration 6.2.2.1. Oral 6.2.2.2. Topical 6.2.2.3. Subcutaneous Pellets 6.2.2.4. Injections 6.2.2.5. Others 6.2.3. By End-User 6.2.3.1. Hospitals 6.2.3.2. Clinics 6.2.3.3. Pharmacy Store 6.2.3.4. Others 6.2.4. By Country 6.2.4.1. US 6.2.4.2. Canada 6.2.4.3. Mexico 6.2.5. Company Market Share (Top 3-5) 6.2.6. Economic Impact Study on North America Estrogen Replacement Therapy Market 7. Europe Estrogen Replacement Therapy Market Overview 7.1. Europe Estrogen Replacement Therapy Market Size & Forecast, 2016-2027 7.1.1. Demand 7.1.1.1. By Value (USD Million) 7.2. Europe Estrogen Replacement Therapy Market Share & Forecast, 2016-2027 7.2.1. By Dosage Forms 7.2.1.1. Patches 7.2.1.2. Tablets 7.2.1.3. Gels/Creams 7.2.1.4. Suppositories Implants 7.2.1.5. Injections 7.2.2. By Routes of Administration 7.2.2.1. Oral 7.2.2.2. Topical 7.2.2.3. Subcutaneous Pellets 7.2.2.4. Injections 7.2.2.5. Others 7.2.3. By End-User 7.2.3.1. Hospitals 7.2.3.2. Clinics 7.2.3.3. Pharmacy Store 7.2.3.4. Others 7.2.4. By Country 7.2.4.1. Germany 7.2.4.2. UK 7.2.4.3. France 7.2.4.4. Italy 7.2.4.5. Rest of Europe 7.2.5. Company Market Share (Top 3-5) 7.2.6. Economic Impact Study on Europe Estrogen Replacement Therapy Market 8. Asia Pacific Estrogen Replacement Therapy Market Overview 8.1. Asia Pacific Estrogen Replacement Therapy Market Size & Forecast, 2016-2027 8.1.1. Demand 8.1.1.1. By Value (USD Million) 8.2. Asia Pacific Estrogen Replacement Therapy Market Share & Forecast, 2016-2027 8.2.1. By Dosage Forms 8.2.1.1. Patches 8.2.1.2. Tablets 8.2.1.3. Gels/Creams 8.2.1.4. Suppositories Implants 8.2.1.5. Injections 8.2.2. By Routes of Administration 8.2.2.1. Oral 8.2.2.2. Topical 8.2.2.3. Subcutaneous Pellets 8.2.2.4. Injections 8.2.2.5. Others 8.2.3. By End-User 8.2.3.1. Hospitals 8.2.3.2. Clinics 8.2.3.3. Pharmacy Store 8.2.3.4. Others 8.2.4. By Country 8.2.4.1. China 8.2.4.2. India 8.2.4.3. Japan 8.2.4.4. Australia 8.2.4.5. Rest of Asia Pacific 8.2.5. Company Market Share (Top 3-5) 8.2.6. Economic Impact Study on Asia Pacific Estrogen Replacement Therapy Market 9. South America Estrogen Replacement Therapy Market Overview 9.1. South America Estrogen Replacement Therapy Market Size & Forecast, 2016-2027 9.1.1. Demand 9.1.1.1. By Value (USD Million) 9.2. South America Estrogen Replacement Therapy Market Share & Forecast, 2016-2027 9.2.1. By Dosage Forms 9.2.1.1. Patches 9.2.1.2. Tablets 9.2.1.3. Gels/Creams 9.2.1.4. Suppositories Implants 9.2.1.5. Injections 9.2.2. By Routes of Administration 9.2.2.1. Oral 9.2.2.2. Topical 9.2.2.3. Subcutaneous Pellets 9.2.2.4. Injections 9.2.2.5. Others 9.2.3. By End-User 9.2.3.1. Hospitals 9.2.3.2. Clinics 9.2.3.3. Pharmacy Store 9.2.3.4. Others 9.2.4. By Country 9.2.4.1. Brazil 9.2.4.2. Argentina 9.2.4.3. Rest of South America 9.2.5. Company Market Share (Top 3-5) 9.2.6. Economic Impact Study on South America Estrogen Replacement Therapy Market 10. Middle East & Africa Estrogen Replacement Therapy Market Overview 10.1. Middle East & Africa Estrogen Replacement Therapy Market Size & Forecast, 2016-2027 10.1.1. Demand 10.1.1.1. By Value (USD Million) 10.2. Middle East & Africa Estrogen Replacement Therapy Market Share & Forecast, 2016-2027 10.2.1. By Dosage Forms 10.2.1.1. Patches 10.2.1.2. Tablets 10.2.1.3. Gels/Creams 10.2.1.4. Suppositories Implants 10.2.1.5. Injections 10.2.2. By Routes of Administration 10.2.2.1. Oral 10.2.2.2. Topical 10.2.2.3. Subcutaneous Pellets 10.2.2.4. Injections 10.2.2.5. Others 10.2.3. By End-User 10.2.3.1. Hospitals 10.2.3.2. Clinics 10.2.3.3. Pharmacy Store 10.2.3.4. Others 10.2.4. By Country 10.2.4.1. Saudi Arabia 10.2.4.2. UAE 10.2.4.3. South Africa 10.2.4.4. Rest of Middle East & Africa 10.2.5. Company Market Share (Top 3-5) 10.2.6. Economic Impact Study on Middle East & Africa Estrogen Replacement Therapy Market 11. Competitor Analysis 11.1. Company Description 11.2. Financial Analysis 11.3. Key Products 11.4. Key Management Personnel 11.5. Contact Address 11.6. SWOT Analysis 11.7. Company Profile 11.7.1. AbbVie, Inc. 11.7.2. Bayer AG 11.7.3. Hisamitsu Pharmaceutical Co., Inc. 11.7.4. Novartis AG 11.7.5. Novo Nordisk A/S 11.7.6. Orion Pharma AB 11.7.7. Pfizer, Inc. 11.7.8. Meda pharmaceuticals 11.7.9. Teva Pharmaceutical Industries Ltd. 11.7.10. TherapeuticsMD 11.7.11. Other Prominent Players
| Price : US$ 3500 | Date : Nov 2024 |
| Category : Healthcare and Pharmaceuticals | Pages : 139 |
| Price : US$ 3500 | Date : Nov 2024 |
| Category : Healthcare and Pharmaceuticals | Pages : 116 |
| Price : US$ 3500 | Date : Nov 2024 |
| Category : Healthcare and Pharmaceuticals | Pages : 233 |
| Price : US$ 3500 | Date : Nov 2024 |
| Category : Healthcare and Pharmaceuticals | Pages : 122 |
| Price : US$ 3500 | Date : Nov 2024 |
| Category : Healthcare and Pharmaceuticals | Pages : 123 |
We will be happy to help you find what you need. Please call us or write to us:
Want us to send you latest updates of the current trends, insights, and more, signup to our newsletter (for alerts, special offers, and discounts).
This website is secured Origin CA certificate on the server, Comodo, Firewall and Verified Sitelock Malware Protection
Request Sample 
Request Discount 
Inquire Before Buy
